JY
CDLX icon

Jeff Yass’s Cardlytics CDLX Stock Holding History

Jeff Yass’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Buy
710,300
+659,310
+1,293% +$4.93M ﹤0.01% 5504
2026
Q1 		$535K Sell
50,990
-2,390
-4% -$23.3K ﹤0.01% 9484
2025
Q4 		$614K Sell
53,380
-11,350
-18% -$175K ﹤0.01% 8326
2025
Q3 		$1.57M Buy
64,730
+50,400
+352% +$839K ﹤0.01% 6299
2025
Q2 		$236K Buy
14,330
+5,460
+62% +$94.3K ﹤0.01% 10884
2025
Q1 		$161K Sell
8,870
-5,400
-38% -$154K ﹤0.01% 11157
2024
Q4 		$529K Sell
14,270
-26,830
-65% -$1.03M ﹤0.01% 8520
2024
Q3 		$1.32M Buy
41,100
+3,840
+10% +$213K ﹤0.01% 6207
2024
Q2 		$3.06M Buy
37,260
+16,140
+76% +$1.75M ﹤0.01% 4276
2024
Q1 		$3.06M Buy
21,120
+4,850
+30% +$410K ﹤0.01% 4478
2023
Q4 		$1.5M Sell
16,270
-13,190
-45% -$1.34M ﹤0.01% 6016
2023
Q3 		$4.86M Buy
29,460
+26,850
+1,029% +$3.49M ﹤0.01% 3578
2023
Q2 		$165K Sell
2,610
-5,120
-66% -$310K ﹤0.01% 10472
2023
Q1 		$263K Buy
7,730
+4,650
+151% +$243K ﹤0.01% 10018
2022
Q4 		$178K Buy
3,080
+1,440
+88% +$89K ﹤0.01% 10291
2022
Q3 		$154K Buy
+1,640
New +$233K ﹤0.01% 11195
2022
Q2 		– Sell
-1,510
Closed -$830K – 12964
2022
Q1 		$830K Buy
1,510
+400
+36% +$242K ﹤0.01% 7618
2021
Q4 		$734K Sell
1,110
-1,190
-52% -$910K ﹤0.01% 8120
2021
Q3 		$1.93M Sell
2,300
-710
-24% -$720K ﹤0.01% 5916
2021
Q2 		$3.82M Buy
3,010
+550
+22% +$621K ﹤0.01% 4529
2021
Q1 		$2.7M Sell
2,460
-880
-26% -$1.16M ﹤0.01% 5204
2020
Q4 		$4.77M Sell
3,340
-2,160
-39% -$2.3M ﹤0.01% 3471
2020
Q3 		$3.88M Sell
5,500
-1,260
-19% -$916K ﹤0.01% 3418
2020
Q2 		$4.73M Buy
6,760
+3,970
+142% +$2.29M ﹤0.01% 3085
2020
Q1 		$975K Buy
+2,790
New +$1.98M ﹤0.01% 5468

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jeff Yass's CDLX Position: Q2 2026 in Review

Jeff Yass sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 1,592 shares — an estimated $11.9K sold.

Jeff Yass first reported a position in CDLX in Q3 2019 and held it in 24 quarters. The position peaked at $4.22M in Q4 2020. 41 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Jeff Yass reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 1,592 Cardlytics shares in Q2 2026, an estimated $11.9K.
  • Jeff Yass first reported a position in Cardlytics in Q3 2019 and held it in 24 quarters.
  • Jeff Yass's Cardlytics position peaked at $4.22M in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.